Rob Riemsma
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
-
- Pain Management and Opioid Use
Papers in
- Rheumatology 11
- Rheumatoid Arthritis Research and Therapies 7
- Spondyloarthritis Studies and Treatments 5
- Co-authors
- Jos Kleijnen (36 shared papers)Kate Misso (14 shared papers)Kate Light (4 shared papers)Nerys Woolacott (3 shared papers)Lisa Mather (3 shared papers)Zarnie Khadjesari (3 shared papers)Gill Worthy (11 shared papers)Nigel Armstrong (21 shared papers)
- Journals
- PharmacoEconomics (13 papers)Health Technology Assessment (10 papers)Current Medical Research and Opinion (3 papers)Clinical Rheumatology (1 paper)BMC Medicine (1 paper)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Rob Riemsma
51 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 123
- Rheumatology 254
- Anesthesiology and Pain Medicine 85
- Applied Psychology 66
- Immunology 187
- Pharmacology 143
Countries citing papers authored by Rob Riemsma
This map shows the geographic impact of Rob Riemsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Riemsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Riemsma more than expected).
Fields of papers citing papers by Rob Riemsma
This network shows the impact of papers produced by Rob Riemsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Riemsma. The network helps show where Rob Riemsma may publish in the future.
Co-authors
The 25 scholars most cited alongside Rob Riemsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 200 | |
| 2 | 2003 | 169 | |
| 3 | 1998 | 120 | |
| 4 | 2001 | 102 | |
| 5 | 2006 | 90 | |
| 6 | 2012 | 74 | |
| 7 | Epidemiology of chronic pain and its treatment in The Netherlands. | 2011 | 71 |
| 8 | 2011 | 67 | |
| 9 | 2017 | 65 | |
| 10 | 2010 | 64 | |
| 11 | 2002 | 63 | |
| 12 | 2012 | 60 | |
| 13 | 2005 | 58 | |
| 14 | 2016 | 52 | |
| 15 | 2007 | 49 | |
| 16 | 2009 | 42 | |
| 17 | 2010 | 41 | |
| 18 | 2013 | 40 | |
| 19 | 2016 | 31 | |
| 20 | Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. | 2007 | 28 |
About Rob Riemsma
Rob Riemsma is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Oncology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Ophthalmology and Visual Impairment Studies (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Opioid Use Disorder Treatment (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Rheumatology (254 citations), Anesthesiology and Pain Medicine (85 citations), Applied Psychology (66 citations), Immunology (187 citations) and Pharmacology (143 citations). Rob Riemsma has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Jos Kleijnen, Kate Misso, Kate Light, Nerys Woolacott, Lisa Mather, Zarnie Khadjesari, Gill Worthy, Nigel Armstrong, Mark Sculpher and Yolanda Bravo Vergel. Their work appears in journals such as PharmacoEconomics, Health Technology Assessment, Current Medical Research and Opinion, Clinical Rheumatology and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.